Affordable Access

deepdyve-link
Publisher Website

Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer.

Authors
  • Llukani, Elton1
  • Katz, Benjamin F2
  • Agalliu, Ilir3
  • Lightfoot, Andrew2
  • Yu, Sue-Jean S2
  • Kathrins, Martin2
  • Lee, Ziho4
  • Su, Yu-Kai2
  • Monahan Agnew, Kelly2
  • McGill, Alice2
  • Eun, Daniel D4
  • Lee, David I2
  • 1 Division of Urology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; Department of Urology, New York University School of Medicine, New York, NY, USA.
  • 2 Division of Urology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
  • 3 Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, NY, USA; Department of Urology, Albert Einstein College of Medicine, New York, NY, USA.
  • 4 Department of Urology, Temple University Health System, Philadelphia, PA, USA.
Type
Published Article
Journal
Prostate international
Publication Date
Mar 01, 2017
Volume
5
Issue
1
Pages
17–23
Identifiers
DOI: 10.1016/j.prnil.2016.12.003
PMID: 28352619
Source
Medline
Keywords
License
Unknown

Abstract

Among men aged 45-64 years low serum pretreatment FT and TT predicted more aggressive features of PrCa in prostatectomy specimens. In middle-aged patients low testosterone levels measured pre-operatively may indicate more aggressive disease parameters.

Report this publication

Statistics

Seen <100 times